Xact Kapitalforvaltning’s Juno Therapeutics, Inc. JUNO Stock Holding History

Xact Kapitalforvaltning’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-7,381	Closed	-$337K	–	1533
2017 Q4	$337K	Buy	+7,381	New	+$368K	0.01%	870

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Xact Kapitalforvaltning's JUNO Position: Q1 2018 in Review

Xact Kapitalforvaltning sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 7,381 shares — an estimated $337K sold.

Xact Kapitalforvaltning first reported a position in JUNO in Q4 2017 and held it in 1 quarter. The position peaked at $337K in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Xact Kapitalforvaltning reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Xact Kapitalforvaltning sold 7,381 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $337K.
Xact Kapitalforvaltning first reported a position in Juno Therapeutics, Inc. in Q4 2017 and held it in 1 quarter.
Xact Kapitalforvaltning's Juno Therapeutics, Inc. position peaked at $337K in Q4 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2018, filed 18 May 2018.